NEU 1.00% $19.90 neuren pharmaceuticals limited

Ann: Neuren completes Phase 2 trial in pediatric Rett syndrome

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.